spacer
 
|


OVERVIEW
The advent of tyrosine kinase inhibitor therapy has transformed the once fatal chronic myelogenous leukemia (CML) into a manageable chronic malignancy, which requires long-term pharmacological disease management. But, each treatment comes with its own risks and benefits, which can substantially affect patients’ quality of life beyond simply extending life. In addition, treatment options change throughout the course of CML. Shared decision-making (SDM) is a process that aims to give patients the care that they want by making informed decisions about treatment options, while clinicians also consider patient preferences and values. SDM is a 2-way discussion designed for the patient and clinician to arrive together at the best treatment plan for that patient. This web-based video activity will employ a case study scenario to show how SDM can be implemented during the course of treating patients with CML. The video activity will also offer guidance on how to implement SDM into each clinical encounter while being mindful of today’s time constraints and complex medical technologies. The video features 2 experienced hematology/oncology clinicians (a physician and a nurse) as well as the executive director of a patient advocacy organization.

GOAL
The goal of this video case study is for medical oncologists, hematologists, hematologist/oncologists, and oncology nurses/advanced practitioners to better understand the role of SDM in the management of patients with CML, as well as how to implement SDM throughout the disease course so that the clinician and patient together can create a treatment plan that is best for that particular patient.

INTENDED AUDIENCE
This web-based video case is designed medical oncologists, hematologists, hematologist/oncologists, and oncology nurses/advanced practitioners. No prerequisites required.

LEARNING OBJECTIVES
Upon the conclusion of this activity, the participant should be able to:
  • IDENTIFY important factors in a patient’s lifestyle and values that assist in shared decision-making.
  • INTEGRATE communication and shared decision making strategies into choosing CML treatment strategies.
DISCLOSURE OF CONFLICTS OF INTEREST
Clinical and Patient Educators Association (CPEA) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices that they or their spouse/life partner have with commercial interests related to the content of this CME activity:

FACULTY
Javier Pinilla-Ibarz, MD, PhD
Associate Member
Director of Immunotherapy
Malignant Hematology Department
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida
Dr Pinilla-Ibarz reports serving as a consultant/independent contractor and serving on a speakers’ bureau for Bristol-Myers Squibb Company; and reports serving as a consultant/independent contractor for ARIAD Pharmaceuticals, Inc, Bristol-Myers Squibb Company, and Novartis; and serving on a speakers’ bureau for Pfizer Inc.

Lisa Nodzon, PhD, ARNP, AOCNP
Department of Malignant Hematology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida
Dr Nodzon reports serving on a speakers’ bureau for Bristol-Myers Squibb Company, Novartis, and Pfizer Inc; and for receiving honoraria from ARIAD Pharmaceuticals Inc and Pharmacyclics.

Sarah Krug, MS
CEO, Cancer101
New York, New York

Ms Krug reports having no significant financial or advisory relationships with corporate organizations related to this activity.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE/CPE activity:

Name of Planner or Manager
Reported Financial Relationship
Ashley Marostica, RN, MSN Nothing to disclose
Amanda Glazar, PhD Nothing to disclose
Andrea Funk Nothing to disclose
Laura Gilsdorf Nothing to disclose

Mary Gabb, MS, and Melinda Castro (ASiM) report having no relevant financial or advisory relationships with corporate organizations related to this activity.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Clinical and Patient Educators Association (CPEA) and ASiM do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Clinical and Patient Educators Association (CPEA) and ASiM. CPEA is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS
Clinical and Patient Educators Association designates this enduring material for a maximum of .75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CPEA Contact Information
For information about the accreditation of this program, please contact CPEA at 303-953-4580 or inquire@cpea-assn.org.

Nursing Continuing Education
Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.

This educational activity for .75 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Global-Logo-smThis activity is jointly provided by Global Education Group and ASiM.


Credit Designation
acpe logoGlobal Education Group designates this continuing education activity for .75 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-15-185-H04-P)

This is a knowledge based activity.

For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com

Estimated time to complete this activity: 40 minutes.

Release Date: November 23, 2015    Expiration Date: November 23, 2017

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

FEE INFORMATION
There is no fee for this educational activity.

SYSTEM REQUIREMENTS
PC: Microsoft Windows 2000 SE or above; Flash Player Plugin (v7.0.1.9 or greater); Internet Explorer (v5.5 or greater), or Firefox; Adobe Acrobat Reader*; MAC: MAC OS 10.2.8; Flash Player Plugin (v7.0.1.9 or greater); Safari; Adobe Acrobat Reader*. *Internet Explorer is not supported on Macintosh systems.

INSTRUCTIONS TO RECEIVE CREDIT
Please complete a brief, unaccredited pre-test before reading this case module. After reading the module, participants may receive credit by completing the CME/CE/CPE test and evaluation online, and receiving a score of 70% or higher. A certificate of participation will be available online immediately following successful completion of the activity.

TABLE OF CONTENTS
Pre-assessment

Using Shared Decision Making to Enhance Provider-Patient Engagement:
Application to Chronic Myelogenous Leukemia

Javier Pinilla-Ibarz MD, PhD, and Lisa Nodzon, PhD, ARNP, AOCNP


Post-assessment

Submit a case to review at event:


procced to pretest


spacer  
  spacer
Advanced Studies in Medicine © 2014 Contact Us
spacer  
spacer